Compare WNW & TXMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WNW | TXMD |
|---|---|---|
| Founded | 2015 | 2008 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Catalog/Specialty Distribution | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 25.8M | 25.9M |
| IPO Year | 2020 | N/A |
| Metric | WNW | TXMD |
|---|---|---|
| Price | $1.78 | $2.17 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 32.2K | ★ 168.3K |
| Earning Date | 05-12-2026 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 1.29 | 0.03 |
| Revenue | $2,550,178.00 | ★ $2,796,000.00 |
| Revenue This Year | N/A | $427.09 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ $1.32 | $82.02 |
| Revenue Growth | ★ 570.49 | 75.19 |
| 52 Week Low | $0.95 | $0.72 |
| 52 Week High | $6.66 | $2.95 |
| Indicator | WNW | TXMD |
|---|---|---|
| Relative Strength Index (RSI) | 63.30 | 50.99 |
| Support Level | $1.40 | $2.36 |
| Resistance Level | $1.56 | $2.95 |
| Average True Range (ATR) | 0.14 | 0.26 |
| MACD | 0.02 | 0.00 |
| Stochastic Oscillator | 84.64 | 21.78 |
Meiwu Technology Co Ltd operates as an online food retail store and franchise restaurants in China. The products offered include green food, organic food, intangible cultural heritage food products, agricultural products bearing geographical indications, and pollution-free products. It operates in three segments including Clean Food platform, Skincare products & service and Technical Service. The company generates the majority of its revenue from Technical services.
TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company and its subsidiaries (i) granted Mayne Pharma an exclusive license to commercialize its IMVEXXY, BIJUVA and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands (collectively, the "Licensed Products") in the United States and its possessions and territories, (ii) assigned to Mayne Pharma its exclusive license to commercialize ANNOVERA (together with the Licensed Products, collectively, the "Products") in the United States and its possessions and territories.